Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple microbial and host protein thiols refer to the sulfhydryl (-SH) groups found on cysteine residues within a wide array of proteins in both pathogens and human cells (Cremers & Jakob, 2013, PubMed). These thiols are essential for maintaining protein structure through disulfide bridges and are critical for the catalytic activity of numerous enzymes, particularly those involved in cellular respiration and metabolism (Lansdown, 2006, PubMed). In the context of pharmacology, these groups serve as a broad-spectrum target for various antiseptic and antimicrobial agents, such as silver ions and oxidizing compounds (Gottardi, 2001, StatPearls). When these agents interact with protein thiols, they cause protein denaturation, inactivation of essential enzymes, and loss of membrane integrity, ultimately leading to cell death (McDonnell & Russell, 1999, Clinical Microbiology Reviews). While highly effective against a diverse range of bacteria, fungi, and viruses, the lack of specificity means these agents can also affect host proteins, often limiting their use to topical applications (Lansdown, 2006, PubMed). Understanding the interaction between drugs and these thiol groups is vital for developing treatments for wound infections and managing oxidative stress-related conditions (Cremers & Jakob, 2013, PubMed).
Drugs targeting these thiols typically act through covalent modification, oxidation, or metal coordination of the sulfhydryl (-SH) groups on cysteine residues (McDonnell & Russell, 1999, Clinical Microbiology Reviews). This interaction leads to the denaturation of structural proteins and the irreversible inhibition of metabolic enzymes, such as those in the electron transport chain (Lansdown, 2006, PubMed). For example, silver ions (Ag+) form stable silver-sulfur bonds, while oxidizing agents like iodine convert thiols into disulfides or sulfenic acids, disrupting the pathogen's cellular homeostasis (Gottardi, 2001, StatPearls).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple microbial and host protein thiols.